Arnold & Porter hosted an interactive webinar on regulatory oversight of digital health and medical technology as it relates to consumer health. Arnold & Porter partners Raqiyyah Pippins, Philip Desjardins, and Jami Mills Vibbert discussed the impact of FDA and FTC regulation on product development decision-making, lifecycle management, privacy and cyber concerns, and other relevant issues facing consumer health companies exploring digital health opportunities.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
